Sélection des publications de l'équipe FRAME
***************
2020
***************
2020
***************
Allard Q, Djerada Z, Pouplard C, Repessé Y, Desprez D, Galinat H, Frotscher B, Berger C, Harroche A, Ryman A, Flaujac C, Chamouni P, Guillet B, Volot F, Szymezak J, Nguyen P, Cazaubon Y.
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
Pharmaceutics. 2020, 12 : 380
Aubert N, Brachet-Botineau M, de Olivera Preto GE, Benz-de Bretagne I, Watier H, Brachet G.
History, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes : Centenarian IgGs lost their neutralization capacity.
Immunol Res. 2020, 68 : 7-12
Cadena Castaneda D, Brachet G, Goupille C, Ouldamer L, Gouilleux-Gruart V.
The neonatal Fc receptor in cancer FcRn in cancer
Cancer Med. 2020, 9 : 4736-4742
Deveuve Q, Lajoie L, Barrault B, Thibault G.
The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
Front Immunol. 2020, 11 : 168
Drillaud N, Ardillon L, Ternisien C, Valentin JB, Fouassier M, Gillet B, Gruel Y, Sigaud M, Horvais V, Bene MC, Trossaërt M.
Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?
Transfus Med Rev. 2020, 34 : 128-129
Ducourau E, Rispens T, Samain M, Dernis E, Le Guilchard F, Andras L, Perdriger A, Lespessailles E, Martin A, Cormier G, Armingeat T, Devauchelle-Pensec V, Gervais E, Le Goff B, de Vries A, Piver E, Paintaud G, Desvignes C, Ternant D, Watier H, Goupille P, Mulleman D.
Methotrexate Effect on Immunogenicity and Long-Term Maintenance of Adalimumab in Axial Spondyloarthritis: A Multicentric Randomised Trial
RMD Open. 2020, 6 (1)
Etienne F, Berthaud M, Nguyen F, Bernardeau K, Maurel C, Bodet-Milin C, Diab M, Abadie J, Gouilleux-Gruart V, Vidal A, Bourgeois M,, Chouin N, Ibisch C, Davodeau F.
SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human.
Front Oncol. 2020 Feb 7;10:20. doi: 10.3389/fonc.2020.00020. eCollection 2020.
Gatault P, Lajoie L, Stojanova J, Halimi JM, Caillard S, Moyrand S, Martinez D, Ladrière M, Morelon E, Merville P, Essig M, Vigneau C, Kamar N, Bouvier N, Westeel PF, Mariat C, Hazzan M, Thierry A, Etienne I, Büchler M, Marquet P, Gouilleux-Gruart V, Thibault G.
The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study
Transpl Int. 2020, 33 : 936-947
Gruel Y, Vayne C, Rollin J, Weber P, Faille D, Bauters A, Macchi L, Alhenc-Gelas M, Lebreton A, De Maistre E, Voisin S, Gouilleux-Gruart V, Perrin J, Tardy-Poncet B, Elalamy I, Lavenu-Bombled C, Mouton C, Biron C, Ternisien C, Nedelec-Gac F, Duchemin J, De Raucourt E, Gouin-Thibault I, Rugeri L, Tardy B, Giraudeau B, Bejan-Angoulvant T, Pouplard C.
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
Thromb Haemost. 2020 Jun 22. doi: 10.1055/s-0040-1712957. [Epub ahead of print]
Gruel Y, De Maistre E, Pouplard C, Mullier F, Susen S, Roullet S, Blais N, Le Gal G, Vincentelli A, Lasne D, Lecompte T, Albaladejo P, Godier A, Members of the French Working Group on Perioperative Haemostasis Groupe d’intérêt en hémostase périopératoire GIHP
Diagnosis and management of heparin-induced thrombocytopenia
Anaesth Crit Care Pain Med. 2020, 39 : 291-310
Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzalla I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group).
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: guidelines from the French BIMHO group (GFHT).
Eur J Haematol. 2020 Apr 10. doi: 10.1111/ejh.13423. [Epub ahead of print]
Lamendour L, Deluce-Kakwata-Nkor N, Mouline C, Gouilleux-Gruart V, Velge-Roussel F.
Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
Int J Mol Sci. 2020 Jul 24;21(15):E5259.
Odent T, de Courtivron B, Gruel Y.
Thrombotic risk in children undergoing orthopedic surgery.
Orthop Traumatol Surg Res. 2020 Feb;106(1S):S109-S114
Pouplard C, Sattler L, Ryman A, Eschwege V, De Maistre E, Flaujac C, Szymezak J, Grand F, Repesse Y, Galinat H, Donnard M, Ternisien C, Iorio A, Chelle P, Jeanpierre E; ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT).
Multicentre pharmacokinetic evaluation of rFVIII-Fc (efmoroctocog alfa) in a real life and comparison with non-extended half-life FVIII concentrates.
Haemophilia. 2020, 26 : 282-289.
Susen S, Tacquard CA, Godon A, Mansour A, Garrigue D, Nguyen P, Godier A, Testa S, Levy JH, Albaladejo P, Gruel Y; GIHP and GFHT.
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.
Crit Care. 2020, 24 : 364
Tardy B, Lecompte T, Mullier F, Vayne C, Pouplard C.
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
J Clin Med. 2020, 9: 1226
Vayne C, Guéry EA, Charuel N, Besombes J, Lambert WC, Rollin J, Gruel Y, Pouplard C.
Evaluation of Functional Assays for the Diagnosis of Heparin Induced Thrombocytopenia Using 5B9, a Monoclonal IgG That Mimics Human Antibodies.
J Thromb Haemost. 2020 Jan 29[Online ahead of print]
Vayne C, Guéry EA, Rollin J, Baglo T, Petermann R, Gruel Y.
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia.
J Clin Med. 2020 Jul 13;9(7):E2212. doi: 10.3390/jcm9072212.
Wolff M, Handtke S, Palankar R, Wesche J, Kohler TP, Kohler C, Gruel Y, Hammerschmidt S, Greinacher A.
Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae - The role of FcγRIIa and platelet factor 4/heparin-antibodies.
J Thromb Haemost. 2020 Apr 1. doi: 10.1111/jth.14814. [Epub ahead of print]
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
Pharmaceutics. 2020, 12 : 380
Aubert N, Brachet-Botineau M, de Olivera Preto GE, Benz-de Bretagne I, Watier H, Brachet G.
History, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes : Centenarian IgGs lost their neutralization capacity.
Immunol Res. 2020, 68 : 7-12
Cadena Castaneda D, Brachet G, Goupille C, Ouldamer L, Gouilleux-Gruart V.
The neonatal Fc receptor in cancer FcRn in cancer
Cancer Med. 2020, 9 : 4736-4742
Deveuve Q, Lajoie L, Barrault B, Thibault G.
The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
Front Immunol. 2020, 11 : 168
Drillaud N, Ardillon L, Ternisien C, Valentin JB, Fouassier M, Gillet B, Gruel Y, Sigaud M, Horvais V, Bene MC, Trossaërt M.
Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII?
Transfus Med Rev. 2020, 34 : 128-129
Ducourau E, Rispens T, Samain M, Dernis E, Le Guilchard F, Andras L, Perdriger A, Lespessailles E, Martin A, Cormier G, Armingeat T, Devauchelle-Pensec V, Gervais E, Le Goff B, de Vries A, Piver E, Paintaud G, Desvignes C, Ternant D, Watier H, Goupille P, Mulleman D.
Methotrexate Effect on Immunogenicity and Long-Term Maintenance of Adalimumab in Axial Spondyloarthritis: A Multicentric Randomised Trial
RMD Open. 2020, 6 (1)
Etienne F, Berthaud M, Nguyen F, Bernardeau K, Maurel C, Bodet-Milin C, Diab M, Abadie J, Gouilleux-Gruart V, Vidal A, Bourgeois M,, Chouin N, Ibisch C, Davodeau F.
SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human.
Front Oncol. 2020 Feb 7;10:20. doi: 10.3389/fonc.2020.00020. eCollection 2020.
Gatault P, Lajoie L, Stojanova J, Halimi JM, Caillard S, Moyrand S, Martinez D, Ladrière M, Morelon E, Merville P, Essig M, Vigneau C, Kamar N, Bouvier N, Westeel PF, Mariat C, Hazzan M, Thierry A, Etienne I, Büchler M, Marquet P, Gouilleux-Gruart V, Thibault G.
The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study
Transpl Int. 2020, 33 : 936-947
Gruel Y, Vayne C, Rollin J, Weber P, Faille D, Bauters A, Macchi L, Alhenc-Gelas M, Lebreton A, De Maistre E, Voisin S, Gouilleux-Gruart V, Perrin J, Tardy-Poncet B, Elalamy I, Lavenu-Bombled C, Mouton C, Biron C, Ternisien C, Nedelec-Gac F, Duchemin J, De Raucourt E, Gouin-Thibault I, Rugeri L, Tardy B, Giraudeau B, Bejan-Angoulvant T, Pouplard C.
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
Thromb Haemost. 2020 Jun 22. doi: 10.1055/s-0040-1712957. [Epub ahead of print]
Gruel Y, De Maistre E, Pouplard C, Mullier F, Susen S, Roullet S, Blais N, Le Gal G, Vincentelli A, Lasne D, Lecompte T, Albaladejo P, Godier A, Members of the French Working Group on Perioperative Haemostasis Groupe d’intérêt en hémostase périopératoire GIHP
Diagnosis and management of heparin-induced thrombocytopenia
Anaesth Crit Care Pain Med. 2020, 39 : 291-310
Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzalla I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group).
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: guidelines from the French BIMHO group (GFHT).
Eur J Haematol. 2020 Apr 10. doi: 10.1111/ejh.13423. [Epub ahead of print]
Lamendour L, Deluce-Kakwata-Nkor N, Mouline C, Gouilleux-Gruart V, Velge-Roussel F.
Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
Int J Mol Sci. 2020 Jul 24;21(15):E5259.
Odent T, de Courtivron B, Gruel Y.
Thrombotic risk in children undergoing orthopedic surgery.
Orthop Traumatol Surg Res. 2020 Feb;106(1S):S109-S114
Pouplard C, Sattler L, Ryman A, Eschwege V, De Maistre E, Flaujac C, Szymezak J, Grand F, Repesse Y, Galinat H, Donnard M, Ternisien C, Iorio A, Chelle P, Jeanpierre E; ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT).
Multicentre pharmacokinetic evaluation of rFVIII-Fc (efmoroctocog alfa) in a real life and comparison with non-extended half-life FVIII concentrates.
Haemophilia. 2020, 26 : 282-289.
Susen S, Tacquard CA, Godon A, Mansour A, Garrigue D, Nguyen P, Godier A, Testa S, Levy JH, Albaladejo P, Gruel Y; GIHP and GFHT.
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.
Crit Care. 2020, 24 : 364
Tardy B, Lecompte T, Mullier F, Vayne C, Pouplard C.
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
J Clin Med. 2020, 9: 1226
Vayne C, Guéry EA, Charuel N, Besombes J, Lambert WC, Rollin J, Gruel Y, Pouplard C.
Evaluation of Functional Assays for the Diagnosis of Heparin Induced Thrombocytopenia Using 5B9, a Monoclonal IgG That Mimics Human Antibodies.
J Thromb Haemost. 2020 Jan 29[Online ahead of print]
Vayne C, Guéry EA, Rollin J, Baglo T, Petermann R, Gruel Y.
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia.
J Clin Med. 2020 Jul 13;9(7):E2212. doi: 10.3390/jcm9072212.
Wolff M, Handtke S, Palankar R, Wesche J, Kohler TP, Kohler C, Gruel Y, Hammerschmidt S, Greinacher A.
Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae - The role of FcγRIIa and platelet factor 4/heparin-antibodies.
J Thromb Haemost. 2020 Apr 1. doi: 10.1111/jth.14814. [Epub ahead of print]
